Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T, Nakahara K, Yamada H, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T. Fujimoto T, et al. Among authors: kurachi h. Gynecol Oncol. 2007 Nov;107(2):253-9. doi: 10.1016/j.ygyno.2007.06.009. Epub 2007 Jul 19. Gynecol Oncol. 2007. PMID: 17640720
Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T, Nakahara K, Shoji T, Sugiyama T, Takano T, Yaegashi N, Yokoyama Y, Mizunuma H, Tase R, Satou H, Tanaka T, Motoyama T, Kurachi H. Kojimahara T, et al. Among authors: kurachi h. Tohoku J Exp Med. 2011 Feb;223(2):91-6. doi: 10.1620/tjem.223.91. Tohoku J Exp Med. 2011. PMID: 21263209 Free article.
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Shoji T, Takatori E, Omi H, Kumagai S, Yoshizaki A, Yokoyama Y, Mizunuma H, Fujimoto T, Takano T, Yaegashi N, Tase T, Nakahara K, Kurachi H, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: kurachi h. Int J Gynecol Cancer. 2011 Jan;21(1):44-50. doi: 10.1097/IGC.0b013e3181ffbe9f. Int J Gynecol Cancer. 2011. PMID: 21330830 Clinical Trial.
Investigation of the clinicopathological features of fallopian tube malignancy.
Yokoyama Y, Futagami M, Fujimoto T, Terada Y, Takatori E, Sugiyama T, Otsuki T, Yaegashi N, Kojimahara T, Kurachi H, Nishiyama H, Fujimori K, Tase T, Mizunuma H. Yokoyama Y, et al. Among authors: kurachi h. Oncol Rep. 2013 Jul;30(1):79-84. doi: 10.3892/or.2013.2439. Epub 2013 Apr 30. Oncol Rep. 2013. PMID: 23633088
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.
Takano T, Otsuki T, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, Niikura H, Ito K, Yaegashi N, Yamada H, Tase T, Kagabu M, Shoji T, Sugiyama T, Sato N, Fujimoto T, Terada Y, Nakahara K, Kurachi H, Yokoyama Y, Mizunuma H, Soeda S, Nishiyama H, Matsumoto T, Sato S, Shimada M, Kigawa J. Takano T, et al. Among authors: kurachi h. Int J Clin Oncol. 2014 Dec;19(6):1052-8. doi: 10.1007/s10147-013-0658-y. Epub 2014 Jan 7. Int J Clin Oncol. 2014. PMID: 24395448 Clinical Trial.
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer.
Yokoyama Y, Futagami M, Watanabe J, Sato N, Terada Y, Miura F, Sugiyama T, Takano T, Yaegashi N, Kojimahara T, Kurachi H, Nishiyama H, Fujimori K, Tase T, Mizunuma H. Yokoyama Y, et al. Among authors: kurachi h. Mol Clin Oncol. 2014 Mar;2(2):212-218. doi: 10.3892/mco.2013.223. Epub 2013 Dec 10. Mol Clin Oncol. 2014. PMID: 24649335 Free PMC article.
242 results